|
End-of-day quote
Nasdaq
05/02/2024
|
5-day change | 1st Jan Change | ||
| 0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
| Market Cap | 23Cr 19Cr 18Cr 17Cr 31Cr 2.14TCr 31Cr 216.32Cr 84Cr 1.09TCr 85Cr 83Cr 3.48TCr | P/E 2026 * |
-1.34x | P/E 2027 * | -1.99x |
|---|---|---|---|---|---|
| Enterprise Value | 23Cr 19Cr 18Cr 17Cr 31Cr 2.14TCr 31Cr 216.32Cr 84Cr 1.09TCr 85Cr 83Cr 3.48TCr | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 2.04x |
| Free-Float |
99.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Tonix Pharmaceuticals
| 1 day | -2.36% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 16/11/2007 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 01/02/2016 |
Errol Gould
CTO | Chief Tech/Sci/R&D Officer | - | 03/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 01/10/2011 |
Margaret Bell
BRD | Director/Board Member | 66 | 12/09/2017 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 05/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | +2.32% | - | - | 23Cr | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,00200Cr | |
| -2.22% | -0.76% | +51.08% | +67.61% | 65TCr | |
| -2.99% | -4.31% | +18.59% | +66.94% | 44TCr | |
| -0.29% | -0.14% | +29.29% | +37.34% | 35TCr | |
| -0.01% | -15.20% | +9.11% | +26.10% | 26TCr | |
| -1.25% | -2.38% | -2.38% | +11.32% | 25TCr | |
| -10.08% | -10.26% | +40.32% | +51.55% | 21TCr | |
| -1.09% | -4.44% | -14.90% | -57.85% | 20TCr | |
| -2.88% | -2.19% | +26.54% | +92.95% | 18TCr | |
| Average | -0.57% | -2.06% | +23.31% | +43.07% | 39.37TCr | |
| Weighted average by Cap. | +0.04% | -2.39% | +32.71% | +57.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.5Cr 4.73Cr 4.45Cr 4.06Cr 7.58Cr 521.45Cr 7.62Cr 53Cr 20Cr 266.53Cr 21Cr 20Cr 848.15Cr | 11Cr 9.53Cr 8.97Cr 8.19Cr 15Cr 1.05TCr 15Cr 106.28Cr 41Cr 537.33Cr 42Cr 41Cr 1.71TCr |
| Net income | -17Cr -15Cr -14Cr -12Cr -23Cr -1.6TCr -23Cr -161.71Cr -63Cr -817.62Cr -63Cr -62Cr -2.6TCr | -16Cr -14Cr -13Cr -12Cr -23Cr -1.56TCr -23Cr -157.47Cr -61Cr -796.14Cr -62Cr -60Cr -2.53TCr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TNXP Stock
- TNXP Stock
Select your edition
All financial news and data tailored to specific country editions
